The bank garnered bids close to $3 billion from institutional investors in Asia, which included bids for the bank’s first sustainable bond, which has a three-year tenure and another bond which had a five-year tenure, sources aware of the development told ET.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the